Registration statement for securities of certain foreign private issuers

Business Acquisitions (Tables)

v3.21.2
Business Acquisitions (Tables)
12 Months Ended
Dec. 31, 2020
Statement [Line Items]  
Summary of Aggregate Purchase Price of the Acquisition
The aggregate purchase price of the acquisition has been allocated on a preliminary basis as follows:
 
    
2021
 
    
$’000
 
Cash paid, net of cash acquired
     13,835  
Issuance of warrants
     2,349  
    
 
 
 
Aggregate purchase price
  
 
16,184
 
   
Accounts receivable
     1,534  
Customer relationships
     10,800  
Physician’s network
     3,500  
Trademark
     1,900  
License
     590  
Healthcare related liabilities
     (11,247
Other assets and liabilities, net
     (4,364
    
 
 
 
Net assets acquired
  
 
2,713
 
    
 
 
 
Amount allocated to goodwill
  
 
13,471
 
Fresno [Member]  
Statement [Line Items]  
Summary of Aggregate Purchase Price of the Acquisition
The estimated fair value of assets acquired as of the acquisition date were as follows:
 
    
Recognized values on acquisition
 
    
$‘000
 
Acquiree’s net assets at the acquisition date:
        
Intangible assets
     7,900  
Right-of-use
asset
     153  
Lease liability
     (153
    
 
 
 
Net identifiable assets and liabilities
  
 
7,900
 
Goodwill
     17,771  
    
 
 
 
Consideration paid
  
 
25,671
 
    
 
 
 
Health Innovators Inc [Member]  
Statement [Line Items]  
Summary of Aggregate Purchase Price of the Acquisition
Effect of acquisition
The acquisition had the following effect on the Group’s assets and liabilities.
 
    
Recognized values on acquisition
 
    
$‘000
 
Acquiree’s net assets at the acquisition date:
        
Intangible assets
     940  
Working capital
     27  
Cash and cash equivalents
     4,230  
Deferred tax liabilities
     (160
Debt
     (1,098
    
 
 
 
Net identifiable assets and liabilities
  
 
3,939
 
Goodwill
     61  
    
 
 
 
Consideration paid
  
 
4,000